View from the Thoraxcenter: ESC 22 Late-breaking Science Preview

  • Видео
  • О видео
  • Скачать
  • Поделиться

View from the Thoraxcenter: ESC 22 Late-breaking Science Preview

Watch on Radcliffe Cardiology: https://www.icrjournal.com/video-index/view-thoraxcenter-esc-22-late-breaking-science-preview?utm_source=youtube&utm_medium=organic_social&utm_term=&utm_campaign=DELV-6605&utm_content=esc_thoraxpreview In this short and engaging episode of View from the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) share their take on the most impactful hot-line and late-breaking trials from ESC 2022. Which trials should we look out for during the weekend? Trials covered in detail include: TAILOR-PCI: Tailored Antiplatelet Therapy Following PCI ASCEND: A Study of Cardiovascular Events iN Diabetes REDUCE-IT: A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High-Risk Patients With Hypertriglyceridemia and on Statin COAPT: Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation PHYSIC: The Precision Hypertension Care Study EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction) RIVER: RIvaroxaban for Valvular Heart diseasE and atRial Fibrillation Trial REVIVED-BCIS2: Study of Efficacy and Safety of Percutaneous Coronary Intervention to Improve Survival in Heart Failure PACIFIC-AMI: Study to Gather Information About the Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following an Acute Heart Attack AI-ENHANCED: Enhanced Diagnosis of Severe Aortic Stenosis Using Artificial Intelligence: A Proof-of-Concept Study of 530,871 Echocardiograms PREFFIR: Prediction of Recurrent Events With 18F-Fluoride FRAME-AMI: FFR Versus Angiography-Guided Strategy for Management of AMI With Multivessel Disease PANTHER: P2Y12 inhibitor or Aspirin moNoTHERapy as secondary prevention in patients with coronary artery disease: in individual patient data meta-analysis This content is intended for healthcare professionals only. Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.
499   |   2 год. назад  |   3 - 0
 

View from the Thoraxcenter: ESC 22 Late-breaking Science Preview

Скачайте изображение (превью) выбрав качество


320x180 480x360 640x480 1280x720

Watch on Radcliffe Cardiology:

In this short and engaging episode of View from the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) share their take on the most impactful hot-line and late-breaking trials from ESC 2022.

Which trials should we look out for during the weekend?

Trials covered in detail include:
TAILOR-PCI: Tailored Antiplatelet Therapy Following PCI
ASCEND: A Study of Cardiovascular Events iN Diabetes
REDUCE-IT: A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High-Risk Patients With Hypertriglyceridemia and on Statin
COAPT: Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation
PHYSIC: The Precision Hypertension Care Study
EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)
RIVER: RIvaroxaban for Valvular Heart diseasE and atRial Fibrillation Trial
REVIVED-BCIS2: Study of Efficacy and Safety of Percutaneous Coronary Intervention to Improve Survival in Heart Failure
PACIFIC-AMI: Study to Gather Information About the Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following an Acute Heart Attack
AI-ENHANCED: Enhanced Diagnosis of Severe Aortic Stenosis Using Artificial Intelligence: A Proof-of-Concept Study of 530,871 Echocardiograms
PREFFIR: Prediction of Recurrent Events With 18F-Fluoride
FRAME-AMI: FFR Versus Angiography-Guided Strategy for Management of AMI With Multivessel Disease
PANTHER: P2Y12 inhibitor or Aspirin moNoTHERapy as secondary prevention in patients with coronary artery disease: in individual patient data meta-analysis

This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.


View from the Thoraxcenter: ESC 22 Late-breaking Science Preview

Чтобы скачать видео "View from the Thoraxcenter: ESC 22 Late-breaking Science Preview" передвинте ползунок вправо



Покажите вашим друзьям, добавьте в соцсети

Ссылка на страницу с видео:

 

Ссылка HTML на страницу с видео:

 

Код для вставки плеера:


  • Комментарии

Комментарии ФБ


Уважаемые друзья!

Источником всего видеоконтента, в том числе проигрывающегося на страницах ресурса ruslar.me, является сторонний видео ресурс, а именно общедоступный видеохостинг YouTube.com, предоставляющий открытый доступ к своему видеоконтенту (используя открытую и общедоступную технологию video API3 youtube.com)!

Проблемы с авторскими правами

Если вам принадлежат авторские права на данное видео, которое было загружено без вашего согласия на YouTube.com, перейдите на страницу этого видео сайта YouTube.com , нажмите на ссылку под проигрывателем Ещё -> "Пожаловаться" -> "Нарушение моих прав" и в выпадающем меню, выбирите, что именно нарушается и нажмите кнопку "Отправить".



Неприемлемый контент

Чтобы сообщить о неприемлемом видео, перейдите на YouTube, нажмите на ссылку под проигрывателем Ещё -> "Пожаловаться" и выберите в "Сообщить о нарушении" что именно вас не устраивает в этом видео. Подробнее о наших правилах читайте в Условиях использования.